<?xml version="1.0" encoding="UTF-8"?>
<p>For special clinical populations, the number needed to be tested ranged from 1.9 in Algeria to 50.3 in Iran, with a median of 12.5. It was 3.9 for countries with a generalized epidemic, 18.1 for countries with a concentrated epidemic, and 8.5 for all the MENA countries.</p>
